Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Male breast cancer: a nation-wide population-based comparison with female breast cancer.
Acta Oncol. 2018 May;57(5):613-621. doi: 10.1080/0284186X.2017.1418088. Epub 2017 Dec 23.
Acta Oncol. 2018.
PMID: 29276849
Physical activity, return to work self-efficacy, and work status among employees undergoing chemotherapy for cancer - a prospective study with 12 months follow-up.
Rosbjerg R, Zachariae R, Hansen DG, Hoejris I, Duijts S, Gehr NL, Andersen ID, Labriola M.
Rosbjerg R, et al. Among authors: hoejris i.
BMC Cancer. 2021 Feb 17;21(1):169. doi: 10.1186/s12885-021-07824-6.
BMC Cancer. 2021.
PMID: 33596859
Free PMC article.
Item in Clipboard
The Predictive Value of Return to Work Self-efficacy for Return to Work Among Employees with Cancer Undergoing Chemotherapy.
Rosbjerg R, Hansen DG, Zachariae R, Hoejris I, Lund T, Labriola M.
Rosbjerg R, et al. Among authors: hoejris i.
J Occup Rehabil. 2020 Dec;30(4):665-678. doi: 10.1007/s10926-020-09882-2.
J Occup Rehabil. 2020.
PMID: 32114672
Free PMC article.
Item in Clipboard
Validation of the Return To Work Self-Efficacy questionnaire in a population of employees undergoing treatment for cancer.
Rosbjerg R, Hansen DG, Zachariae R, Stapelfeldt CM, Hoejris I, Rasmussen MT, Drysdale SW, Labriola M.
Rosbjerg R, et al. Among authors: hoejris i.
Eur J Cancer Care (Engl). 2021 Mar;30(2):e13373. doi: 10.1111/ecc.13373. Epub 2020 Nov 20.
Eur J Cancer Care (Engl). 2021.
PMID: 33216404
Item in Clipboard
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators.
Colleoni M, et al.
Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17.
Lancet Oncol. 2018.
PMID: 29158011
Clinical Trial.
Item in Clipboard
Cite
Cite